Amarantus Bioscience Holdings Inc (AMBS)

[jugs]

You call it a "very positive research report" when, in fact, it's not a research report at all---it is merely a mirroring of possible trading outcomes provided things fall as AMBS hopes. But even Zacks says it is "highly speculative."

Routinely I'll take a contrarian approach to some of Zacks featured tickers and frankly I tend to outperform when I do. I'm a fan of theirs but I suspect most of experienced traders know better than to place any eggs into the Zacks baskets. As for $1/share? I lost 92% of my investment here and Zacks owes sopme of us an apology for that ridiculous blunder.

There seems to be a whole new crop of investors streaming into pennyland's AMBS. Fools they be as it's patently obvious to most of us here that management couldn't care less about the company's destiny. It's all about putting cash into management's hands and nothing more.